Kinnari Patel
President bei ROCKET PHARMACEUTICALS, INC.
Vermögen: 10 Mio $ am 31.03.2024
Profil
Kinnari Patel's current job is as the President, Chief Operating Officer, and Head of R&D at Rocket Pharmaceuticals, Inc. He started this position in 2024.
Dr. Patel's former jobs include being the Head of US Risk Management at Bristol Myers Squibb Co. from 2010 to 2014, and the Chief Operating Officer & Head of Development at Rocket Pharmaceuticals Ltd.
from 2016 to 2021.
Dr. Patel's education history includes an undergraduate and doctorate degree from the University of the Sciences in Philadelphia, as well as an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.02.2024 | 378 903 ( 0,42% ) | 10 Mio $ | 31.03.2024 |
Aktive Positionen von Kinnari Patel
Unternehmen | Position | Beginn |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | President | - |
Ehemalige bekannte Positionen von Kinnari Patel
Unternehmen | Position | Ende |
---|---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Chief Operating Officer | 01.02.2021 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.04.2014 |
Ausbildung von Kinnari Patel
University of the Sciences in Philadelphia | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |